RCT: M-HoLEP Cuts Procedure Time 20% – Patients Go Home the Same Day
After performing holmium laser enucleation of the prostate (HoLEP) to treat benign prostatic hyperplasia (BPH) for 14 years with the same technology, I was excited when Lumenis launched MOSES laser technology, which showed the potential for significant improvement.
Key Benefits of MOSES Technology for BPH and Stones
With several years’ experience treating benign prostatic hyperplasia (BPH) and kidney stones with the Lumenis MOSES Pulse 120H holmium laser with MOSES Technology, I have seen very meaningful benefits for my patients in terms of both outcomes and recovery.
Transform Enucleation into a Day Case, Catheter-Free, with MOSES Technology for HoLEP
For 50% of men over the age of sixty, acquiring a Benign Prostatic Hyperplasia (BPH) is a reality they will face. The enlarged prostate that accompanies BPH means a block of urine flow, resulting in severe bladder complications and extreme discomfort for many men.
Mentoring Through HoLEPs Learning Curve
For treatment of benign prostatic hyperplasia (BPH), transurethral Holmium Laser Enucleation of the Prostate (HoLEP) has emerged as the new gold standard. Compared to other familiar BPH procedures, HoLEP has lower morbidity, less blood loss, more comfortable recovery, a shorter hospital stay, less time with a catheter, and lower retreatment rates.